PF-06305591

DB12106InvestigationalSmall molecule

Pf 06305591 is under investigation in clinical trial NCT01776619 (Safety and Tolerability Study of Multiple Doses of PF-06305591).

Mechanism: Pharmacologically active on Sodium channel protein type 10 subunit alpha
Curator reviewed
Formula / weight: C₁₅H₂₂N₄O · 274.368 g/mol (avg)
Code names: PF-6305591

Resolves to

Compound

Structure

InChIKeyAPWZIFIAVVFPNT-PELKAZGASA-NSMILESC[C@H]([C@H](N)C1=NC2=CC=C(C=C2N1)C(C)(C)C)C(N)=O

Targets

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with PF-06305591, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.